Clinical trial Recruiting at 1 site Observational Ages 18 to 40 Women only

How saliva metabolites change in pregnancy and gum disease

Official title: Salivary Metabolomics of Pregnancy and Periodontal Disease Related Metabolic Pathways

Run by Bezmialem Vakif University · NCT07054177 · Data updated 2026-11-12

This project will test whether saliva metabolites change across pregnancy and after birth by comparing pregnant people to non‑pregnant volunteers to learn how hormonal shifts relate to gum inflammation.

More Pregnancy trials

Quick facts

Study typeObservational
Ages18 Years to 40 Years
SexWomen only
Enrollment30 (estimated)
SponsorBezmialem Vakif University
Academic / other
Locations1 site (Istanbul, Fatih)
StatusRecruiting
StartedJune 24, 2025
Main results expectedMarch 2026
Study endsApril 2026
Registry record updatedJuly 23, 2025
Trial IDNCT07054177 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy pregnant people aged 18–40 with a singleton, uncomplicated pregnancy and non‑pregnant healthy volunteers who meet the listed inclusion criteria.

Probably not a fit

People with systemic disease, BMI over 30, recent antibiotic or anti‑inflammatory use, smoking or alcohol use, or complicated pregnancies are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will collect saliva samples from 15 pregnant volunteers in the 1st, 2nd, and 3rd trimesters and again 6–8 weeks after delivery, plus samples from a matched group of non‑pregnant healthy controls. Clinical periodontal status will be recorded alongside sample collection to link metabolic signals with gum health. Samples will be analyzed using untargeted LC‑MS/MS metabolomics to identify metabolites and pathways associated with pregnancy‑related hormonal changes and periodontal changes. The study is single‑center and longitudinal but relatively small, intended to generate hypotheses and candidate biomarkers for further work.

Why it matters

Potential benefit: If successful, the work could identify saliva markers that help explain or predict pregnancy gingivitis and guide targeted prevention or monitoring.

How similar studies have gone: Previous research has shown pregnancy alters oral microbiota and some saliva biomarkers, but untargeted saliva metabolomics in this specific pregnancy–periodontal context is relatively exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 40 years
* No history of systemic disease or chronic infection
* No use of antibiotics or anti-inflammatory drugs in the last 3 months
* Non-smoker and non-alcohol user
* Willingness to participate by signing the informed consent form

Additional Criteria for Pregnant Volunteers:

* Singleton pregnancy (no multiple gestation)
* Pregnancy progressing without complications (e.g., no diagnosis of preeclampsia, gestational diabetes, or threatened preterm labor)
* Gestational age confirmed by ultrasound

Additional Criteria for Non-Pregnant Control Group:

* No history of pregnancy in the past 6 months
* Regular menstrual cycles
* No history of hormonal disorders (e.g., polycystic ovary syndrome, thyroid dysfunction)

Exclusion Criteria:

* Use of anti-inflammatory or antimicrobial treatments in the past 3 months
* Smoking or alcohol consumption
* Body mass index (BMI) \> 30 kg/m²
* Presence of systemic diseases including diabetes mellitus, hyperprolactinemia, congenital adrenal hyperplasia, androgen-secreting tumors, thyroid dysfunction, Cushing's syndrome, hypertension, liver or kidney dysfunction
* Use of medications that may affect metabolic or hormonal parameters, such as oral contraceptives, steroid hormones, antihypertensives, or insulin-sensitizing drugs
* Periodontal treatment in the past 6 months
* Use of medications known to affect periodontal status (e.g., phenytoin, calcium channel blockers, cyclosporine, warfarin, NSAIDs, aspirin \> 81 mg)
* Active infectious diseases such as hepatitis, HIV, or tuberculosis

Where it's running

  • Bezmialem Vakıf University, Faculty of Dentistry and Faculty of Medicine, Istanbul
    Istanbul, Fatih, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.